Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis

Roberta Guarnone, Esther Centenara, Manuela Zappa, Alberto Zanella, Giovanni Barosi

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

A compensated haemolytic state is defined by decreased red cell life-span without anaemia, i.e. by increased erythropoiesis in the absence of the physiological stimulus for erythropoietin (Epo) production. We evaluated s-Epo levels and the expansion of erythropoiesis (as measured by circulating transferrin receptor, s-TfR) in 32 patients with hereditary spherocytosis (HS) with the aim of verifying whether the enhanced erythropoiesis of compensated haemolysis was Epo-dependent. 20 of the patients (62.5%) bad normal Hb values (> 12 g/dl in females and > 13 g/dl in males). Their compensated haemolytic state was the result of up to 8.2 times normal s-Epo and up to 3.9 times normal s-TfR levels, which were maintained by physiological regulation of erythropoiesis, as documented by the inverse dependence of Hb on s-Epo levels. Considering that patients with iron-deficiency anaemia represented the predicted physiological Epo response to anaemia, the observed/ predicted In s-Epo ratio (O/P ratio) was calculated in HS patients with anaemia and was used as an index of the adequateness of Epo production. All the anaemic HS patients had an O/P ratio > 1, documenting inappropriately high s-Epo levels. This work demonstrates that the compensated haemolytic state of HS patients is produced by an inappropriately high s-Epo level, and that the pattern of Epo overproduction is a biological characteristic of the disease.

Original languageEnglish
Pages (from-to)150-154
Number of pages5
JournalBritish Journal of Haematology
Volume92
Issue number1
Publication statusPublished - 1996

Fingerprint

Hereditary Spherocytosis
Erythropoiesis
Erythropoietin
Anemia
Transferrin Receptors
Iron-Deficiency Anemias
Hemolysis
Reference Values

Keywords

  • Compensated haemolytic state
  • Erythropoiesis
  • Hereditary spherocytosis
  • Serum erythropoietin
  • Serum transferrin receptor

ASJC Scopus subject areas

  • Hematology

Cite this

Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis. / Guarnone, Roberta; Centenara, Esther; Zappa, Manuela; Zanella, Alberto; Barosi, Giovanni.

In: British Journal of Haematology, Vol. 92, No. 1, 1996, p. 150-154.

Research output: Contribution to journalArticle

Guarnone, Roberta ; Centenara, Esther ; Zappa, Manuela ; Zanella, Alberto ; Barosi, Giovanni. / Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis. In: British Journal of Haematology. 1996 ; Vol. 92, No. 1. pp. 150-154.
@article{e9d63517bc024fd3b2e496e846825a5c,
title = "Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis",
abstract = "A compensated haemolytic state is defined by decreased red cell life-span without anaemia, i.e. by increased erythropoiesis in the absence of the physiological stimulus for erythropoietin (Epo) production. We evaluated s-Epo levels and the expansion of erythropoiesis (as measured by circulating transferrin receptor, s-TfR) in 32 patients with hereditary spherocytosis (HS) with the aim of verifying whether the enhanced erythropoiesis of compensated haemolysis was Epo-dependent. 20 of the patients (62.5{\%}) bad normal Hb values (> 12 g/dl in females and > 13 g/dl in males). Their compensated haemolytic state was the result of up to 8.2 times normal s-Epo and up to 3.9 times normal s-TfR levels, which were maintained by physiological regulation of erythropoiesis, as documented by the inverse dependence of Hb on s-Epo levels. Considering that patients with iron-deficiency anaemia represented the predicted physiological Epo response to anaemia, the observed/ predicted In s-Epo ratio (O/P ratio) was calculated in HS patients with anaemia and was used as an index of the adequateness of Epo production. All the anaemic HS patients had an O/P ratio > 1, documenting inappropriately high s-Epo levels. This work demonstrates that the compensated haemolytic state of HS patients is produced by an inappropriately high s-Epo level, and that the pattern of Epo overproduction is a biological characteristic of the disease.",
keywords = "Compensated haemolytic state, Erythropoiesis, Hereditary spherocytosis, Serum erythropoietin, Serum transferrin receptor",
author = "Roberta Guarnone and Esther Centenara and Manuela Zappa and Alberto Zanella and Giovanni Barosi",
year = "1996",
language = "English",
volume = "92",
pages = "150--154",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "1",

}

TY - JOUR

T1 - Erythropoietin production and erythropoiesis in compensated and anaemic states of hereditary spherocytosis

AU - Guarnone, Roberta

AU - Centenara, Esther

AU - Zappa, Manuela

AU - Zanella, Alberto

AU - Barosi, Giovanni

PY - 1996

Y1 - 1996

N2 - A compensated haemolytic state is defined by decreased red cell life-span without anaemia, i.e. by increased erythropoiesis in the absence of the physiological stimulus for erythropoietin (Epo) production. We evaluated s-Epo levels and the expansion of erythropoiesis (as measured by circulating transferrin receptor, s-TfR) in 32 patients with hereditary spherocytosis (HS) with the aim of verifying whether the enhanced erythropoiesis of compensated haemolysis was Epo-dependent. 20 of the patients (62.5%) bad normal Hb values (> 12 g/dl in females and > 13 g/dl in males). Their compensated haemolytic state was the result of up to 8.2 times normal s-Epo and up to 3.9 times normal s-TfR levels, which were maintained by physiological regulation of erythropoiesis, as documented by the inverse dependence of Hb on s-Epo levels. Considering that patients with iron-deficiency anaemia represented the predicted physiological Epo response to anaemia, the observed/ predicted In s-Epo ratio (O/P ratio) was calculated in HS patients with anaemia and was used as an index of the adequateness of Epo production. All the anaemic HS patients had an O/P ratio > 1, documenting inappropriately high s-Epo levels. This work demonstrates that the compensated haemolytic state of HS patients is produced by an inappropriately high s-Epo level, and that the pattern of Epo overproduction is a biological characteristic of the disease.

AB - A compensated haemolytic state is defined by decreased red cell life-span without anaemia, i.e. by increased erythropoiesis in the absence of the physiological stimulus for erythropoietin (Epo) production. We evaluated s-Epo levels and the expansion of erythropoiesis (as measured by circulating transferrin receptor, s-TfR) in 32 patients with hereditary spherocytosis (HS) with the aim of verifying whether the enhanced erythropoiesis of compensated haemolysis was Epo-dependent. 20 of the patients (62.5%) bad normal Hb values (> 12 g/dl in females and > 13 g/dl in males). Their compensated haemolytic state was the result of up to 8.2 times normal s-Epo and up to 3.9 times normal s-TfR levels, which were maintained by physiological regulation of erythropoiesis, as documented by the inverse dependence of Hb on s-Epo levels. Considering that patients with iron-deficiency anaemia represented the predicted physiological Epo response to anaemia, the observed/ predicted In s-Epo ratio (O/P ratio) was calculated in HS patients with anaemia and was used as an index of the adequateness of Epo production. All the anaemic HS patients had an O/P ratio > 1, documenting inappropriately high s-Epo levels. This work demonstrates that the compensated haemolytic state of HS patients is produced by an inappropriately high s-Epo level, and that the pattern of Epo overproduction is a biological characteristic of the disease.

KW - Compensated haemolytic state

KW - Erythropoiesis

KW - Hereditary spherocytosis

KW - Serum erythropoietin

KW - Serum transferrin receptor

UR - http://www.scopus.com/inward/record.url?scp=0030048011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030048011&partnerID=8YFLogxK

M3 - Article

VL - 92

SP - 150

EP - 154

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 1

ER -